|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$296,222
|
$296,222
|
Barchi, Joseph
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 010684
|
$1,506,107
|
$75,305
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$771,635
|
$77,163
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Bladder Cancer Program
|
ZIA BC 011351
|
$161,531
|
$161,531
|
Apolo, Andrea
|
CCR (NCI)
|
|
Botulinum Toxin for Painful Cutaneous Leiomyomas
|
ZIA BC 011177
|
$12,706
|
$6,353
|
Kong, Heidi
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,188,980
|
$118,898
|
Restifo, Nicholas
|
CCR (NCI)
|
|
CALGB Member Site: University of California - San Francisco
|
5U10CA138561-02
|
$112,515
|
$1,125
|
Ryan, Charles
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
CANCER AND INFLAMMATION GENETICS
|
ZIA BC 011300
|
$737,896
|
$221,369
|
Dean, Michael
|
CCR (NCI)
|
|
Cancer and Leukemia Group B
|
3U10CA031946-29S3
|
$8,129,333
|
$81,293
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
7U10CA031946-29
|
$11,034,745
|
$110,347
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
5U10CA032291-29
|
$511,085
|
$5,111
|
Burstein, Harold
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer and Leukemia Group B
|
5U10CA047577-23
|
$104,247
|
$1,042
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
Cancer and Leukemia Group B
|
5U10CA077597-13
|
$95,669
|
$957
|
Liu, Minetta
|
GEORGETOWN UNIVERSITY
|
|
Cancer and Leukemia Group B
|
5U10CA077651-13
|
$218,962
|
$2,190
|
Hudis, Clifford
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Cancer and Leukemia Group B
|
5U10CA041287-25
|
$266,604
|
$2,666
|
KINDLER, HEDY
|
UNIVERSITY OF CHICAGO
|
|
Cancer and Leukemia Group B
|
5U10CA047559-20
|
$164,588
|
$1,646
|
SHEA, THOMAS
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer and Leukemia Group B - Leukemia Correlative Sciences
|
7U10CA101140-08
|
$829,642
|
$8,296
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer and Leukemia Group B - The Ohio State University
|
7U10CA077658-13
|
$503,136
|
$5,031
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
Cancer and Leukemia Group B Statistical Center
|
5U10CA033601-31
|
$2,427,760
|
$24,278
|
GEORGE, STEPHEN
|
DUKE UNIVERSITY
|
|
Cancer and Leukemia Group B Statistical Center
|
7U10CA033601-32
|
$2,478,243
|
$24,782
|
SARGENT, DANIEL
|
MAYO CLINIC
|
|
Cancer and Leukemia Group B: RPCI/SUNYAB
|
5U10CA059518-18
|
$197,247
|
$1,972
|
LEVINE, ELLIS
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Cancer Vaccines and Modulation of Checkpoint Controls in Immunization
|
ZIC BC 010630
|
$452,083
|
$90,417
|
Janik, John
|
CCR (NCI)
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
5U10CA037429-26
|
$11,261,801
|
$112,618
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
CCR Confocal Microscopy Core
|
ZIC BC 010858
|
$584,634
|
$58,463
|
Garfield, Susan
|
CCR (NCI)
|
|
Characterization of Cancer Stem Cells
|
ZIA BC 010794
|
$702,799
|
$421,680
|
Farrar, William
|
CCR (NCI)
|
|
Characterization of the interaction between inflammation and cancer progression
|
ZIA BC 010892
|
$282,216
|
$141,108
|
Wiltrout, Robert
|
CCR (NCI)
|
|
Characterizing a novel tumor recognition mechanism
|
ZIA BC 010803
|
$197,709
|
$197,709
|
Yang, James
|
CCR (NCI)
|
|
City of Hope Southwest Oncology Group Clinical Trials
|
2U10CA046368-23
|
$431,902
|
$4,319
|
MORTIMER, JOANNE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Clinical Fellowship Training Program
|
ZIE BC 011023
|
$324,541
|
$162,271
|
Pinto, Peter
|
CCR (NCI)
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$837,024
|
$502,214
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical production of viral vectors for cancer gene therapy
|
ZIC BC 010989
|
$405,828
|
$60,874
|
Feldman, Steven
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$558,016
|
$418,512
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical Studies to Circumvent Drug Resistance
|
ZIA BC 010620
|
$103,901
|
$25,975
|
Bates, Susan
|
CCR (NCI)
|
|
Computer-Aided Detection of Urinary Tract Cancer on MDCT Urography
|
1R01CA134688-01A2
|
$308,668
|
$154,334
|
Hadjiyski, Lubomir
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics
|
ZIA BC 011123
|
$220,169
|
$110,084
|
Bottaro, Donald
|
CCR (NCI)
|
|
ETIB Clinical Research Core
|
ZID BC 010963
|
$1,520,197
|
$228,030
|
Gress, Ronald
|
CCR (NCI)
|
|
Families at high risk of cancer
|
ZIA CP004410 08285
|
$137,438
|
$13,744
|
Tucker, Margaret
|
DCEG (NCI)
|
|
Generation of T-cell receptors recognizing antigens on non-melanoma tumors
|
ZIA BC 011337
|
$395,418
|
$197,709
|
Yang, James
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$882,683
|
$44,134
|
Gottesman, Michael
|
CCR (NCI)
|
|
Genetics of Renal Disease in African Americans
|
ZIA BC 010022
|
$599,454
|
$599,454
|
Winkler, Cheryl
|
CCR (NCI)
|
|
Growth/Differentiation Factors in Organogenesis
|
ZIA BC 005093
|
$908,425
|
$817,583
|
Perantoni, Alan
|
CCR (NCI)
|
|
Histology Core Laboratory
|
ZIC BC 010687
|
$967,185
|
$48,359
|
Kleiner, David
|
CCR (NCI)
|
|
Human Papillomavirus, HIV, and Penile Cancer Precursors in the Rakai Circumcision
|
ZIA CP010212 10401
|
$42,285
|
$42,285
|
Rabkin, Charles
|
DCEG (NCI)
|
|
Identification of Gene Polymorphisms Associated with Infectious Diseases
|
ZIA BC 010297
|
$599,454
|
$119,891
|
Winkler, Cheryl
|
CCR (NCI)
|
|
Identification of HIF-Regulated Oncogenic Mediators in Renal Cell Carcinoma
|
ZIA BC 011095
|
$73,390
|
$73,390
|
Bottaro, Donald
|
CCR (NCI)
|
|
Identification of Molecular Factors Associated with Response to Interleukin-2
|
ZIA BC 011225
|
$197,709
|
$19,771
|
Yang, James
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$627,828
|
$31,391
|
Khan, Javed
|
CCR (NCI)
|
|
Immunophysiological Mechanisms in the Biological Therapy of Cancer
|
ZIA BC 009262
|
$338,660
|
$169,330
|
Wiltrout, Robert
|
CCR (NCI)
|
|
Inhibitors of Tyrosine Kinase-Dependent Signalling as Anti-Cancer Agents
|
ZIA BC 006198
|
$590,074
|
$442,556
|
Burke, Terrence
|
CCR (NCI)
|
|
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
|
ZIB BC 010906
|
$1,230,133
|
$615,067
|
Waldmann, Thomas
|
CCR (NCI)
|
Total relevant funding to Urinary System for this search: $16,052,372
|